Drawing for AVREEO

USPTO serial 79261084

AVREEO

Reviewed by CopyMark Law Group

Reg. 6109859Status 700Renewal
Filing date
Status date
Registration date
Jul 28, 2020
Examiner
MARCY, AMY ALFIERI
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with AVREEO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $850

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 BENSON DRIVERALEIGH, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine and the musculo-skeletal system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in dermatology and in rheumatology; Pharmaceutical products for the prevention and treatment of cancer and tumors; Pharmaceutical products for the treatment of bone diseases; all the aforesaid goods to be available upon prescription only, not for over-the-counter sale, and none of them for topical administrationACTIVE—
010Medical devices, namely, medical devices for diagnosing or treating respiratory conditions, medical devices for facilitating the inhalation of pharmaceutical preparations; injection devices for medical use, namely, injection devices for pharmaceuticals, injection devices for administering drugs; autoinjectors in the nature of injection devices for the administration of pharmaceutical preparationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 28, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Dec 5, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 16, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 16, 2020FIMPFINAL DISPOSITION PROCESSED—
Oct 28, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 28, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 23, 2020CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Jun 17, 2020APETASSIGNED TO PETITION STAFF—
Jun 4, 2020ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
May 19, 2020EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Mar 25, 2020CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Mar 23, 2020APETASSIGNED TO PETITION STAFF—
Feb 18, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 18, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 18, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 18, 2020EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Nov 26, 2019ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Nov 5, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 5, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 1, 2019GPNXNOTIFICATION PROCESSED BY IB—
Oct 16, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 16, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Oct 16, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 30, 2019ALIEASSIGNED TO LIE—
Sep 23, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 26, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 26, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 26, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 23, 2019RFNTREFUSAL PROCESSED BY IB—
Aug 8, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 8, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 3, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 3, 2019RFRRREFUSAL PROCESSED BY MPU—
Jul 16, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 15, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 10, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 6, 2019DOCKASSIGNED TO EXAMINER—
Jul 6, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 1, 2019LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jun 20, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance